Cumberland Pharmaceuticals (CPIX) Current Assets (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Current Assets data on file, last reported at $32.8 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 2.86% year-over-year to $32.8 million; the trailing twelve-month figure through Mar 2026 stood at $32.8 million (up 2.86% YoY), and the FY2025 full-year result was $37.1 million, up 1.67% from the prior year.
• Current Assets declined to $32.8 million in Q1 2026, from $37.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $49.2 million in Q3 2022 to a low of $29.9 million in Q3 2025.
• A 5-year average of $38.6 million and a median of $36.5 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets increased 4.12% in 2022 and decreased 22.14% in 2023, its largest moves.
• Tracing CPIX's Current Assets over 5 years: stood at $45.9 million in 2022, then declined by 22.14% to $35.7 million in 2023, then advanced by 2.07% to $36.5 million in 2024, then grew by 1.67% to $37.1 million in 2025, then declined by 11.52% to $32.8 million in 2026.
• Business Quant data shows CPIX's Current Assets at $32.8 million in Q1 2026, $37.1 million in Q4 2025, and $29.9 million in Q3 2025.